Assignee
858 THERAPEUTICS INC
US·2 granted patents·1 pending application·1 citations·filing 2022–2024
Top patents by PatentIndex Score
3 records- 0185US11939335B2Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG858 THERAPEUTICS INC·Filed 2023·Granted Mar 26, 2024·1 cites·28 claims
- 0269US12435092B2Substituted imidazo[1,2-A]quinazolines as inhibitors of PARG858 THERAPEUTICS INC·Filed 2024·Granted Oct 7, 2025·0 cites·20 claims
- 0358US2025059207A16,6-fused heterocyclic compounds as mettl3 inhibitors858 THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when 858 THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →